๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Neuromyelitis Optica Spectrum Disorders
Clinical trial register · China

Neuromyelitis Optica Spectrum Disorders Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Guangzhou 3 Wuhan 2 Changsha 2 Tianjin 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing4 Guangzhou3 Wuhan2 Changsha2 Tianjin2
All 15 locations
Target enrolment
to

Neuromyelitis Optica Spectrum Disorders trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Universal Chimeric Antigen Receptor T-Cell ๏ผˆUCAR T-cell๏ผ‰ Therapy Targeting CD19/ BCMA๏ผˆQT-019C๏ผ‰ in Patients With r/ r Neurological Autoimmune Diseases
NCT07392528Neuromyelitis Optica Spectrum Disorders, Multiple Sclerosis, Myasthenia Gravis
Tianjin Huanhu Hospital
Phase EARLY_PHASE1
15
Tianjin
2026-03
Recruiting
Universal Chimeric Antigen Receptor T-Cell ๏ผˆUCAR T-cell๏ผ‰ Therapy Targeting CD19/B Cell Maturation Antigen ๏ผˆCD19/BCMA๏ผ‰ in Patients With r/r Neurological Autoimmune Diseases
NCT06939166Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Tianjin Huanhu Hospital
Phase EARLY_PHASE1
12
Tianjin
2025-06-17
Recruiting
Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
NCT06763848Neuromyelitis Optica Spectrum Disorders
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
144
Guangzhou
2025-04-25
Recruiting
The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
NCT06620809Neuromyelitis Optica Spectrum Disorders
Tongji Hospital
Phase 1
69
Wuhan
2025-03-28
Not yet open
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
NCT06485232Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized, Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
25
Beijing
2025-02-28
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
NCT06413654Neuromyelitis Optica Spectrum Disorders
DrugB001
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
132
Beijing, Cangzhou, Changsha, Chengdu, Fuzhou, Guangzhou, Guiyang, Hangzhou
2024-07-17
Recruiting
Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
NCT06541626Multiple Sclerosis, MS, Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Acute Disseminated Encephalomyelitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
450
Guangzhou
2024-01-01
By invitation
Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
NCT06643858Healthy, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, Neurodegenerative Diseases
Beijing Tiantan Hospital
Observational
10,000
Beijing
2023-12-01
Recruiting
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
NCT06697535Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd
Phase 2
35
Changsha
2023-05-24
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/neuromyelitis-optica-spectrum-disorders

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Neuromyelitis Optica Spectrum Disorders.

How many Neuromyelitis Optica Spectrum Disorders trials are recruiting in China?

6 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neuromyelitis Optica Spectrum Disorders), 10 studies
PhaseStudiesRecruitingShare
Phase EARLY_PHASE13130%
Observational2120%
Not applicable1110%
Phase 11110%
Phase 21110%
Phase 2/31110%
Phase 31010%

Most active sponsors

Lead sponsors with the most studies (Neuromyelitis Optica Spectrum Disorders)
Lead sponsorStudiesRecruiting
Tianjin Huanhu Hospital21
Alexion Pharmaceuticals, Inc.10
Beijing Tiantan Hospital10
Guangzhou JOYO Pharma Co., Ltd11
Shanghai Jiaolian Drug Research and Development Co., Ltd11
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
Third Affiliated Hospital, Sun Yat-Sen University11
Tongji Hospital11
Xuanwu Hospital, Beijing10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.